Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02431494 · ClinicalTrials.gov registry record · NA
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
A NA study, sponsored by Nova Southeastern University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02431494: Clinical Trial NA study, sponsored by Nova Southeastern University.
NCT02431494 is a NA study that was terminated before completion, run by Nova Southeastern University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02431494, a NA study, was terminated before completion, sponsored by Nova Southeastern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations. Although there is consensus that combination therapy is most effective in treating acne, researchers are constantly striving to develop new treatment. Microcurrent therapy (MCT) is a non-invasive modality that has successfully been used to promote wound healing and has been routinely used in aesthetics. Use of MCT alone or in combination with current successful treatment such as blue light phototherapy (BLP), may hold promise for acne treatment. The investigators propose to conduct a small randomized control trial to determine the safety and preliminary efficacy of a novel combination therapy to treat acne vulgaris. The investigators will recruit up to 60 males and females and randomly assign them to one of 3 arms: 1) BLP; 2) MCT; and combination therapy (BLP and MCT). The investigators will assess physiological parameters (number of acne lesions, amount of sebum produced, degree of acne severity) and psychosocial factors (dermatologic quality of life, social anxiety, depressive symptomatology, self-esteem). Participants will complete a baseline assessment prior to initiating treatment and a follow-up assessment at 4 weeks post termination of treatment. The investigators will conduct intermediary assessments at weeks 3 and 5 and 1 week post termination of the treatment. The investigators will use measures of central tendency to describe the sample and repeated measures analysis of variance to compute the main and interaction effects.
Primary Outcome
The investigators will conduct a systematic count of acne lesions (papules and pustules) present in all of the affected areas of the face.
Interventions
- DEVICE Blue light phototherapy
- DEVICE Microcurrent therapy
- DEVICE Combination of BLP and Microcurrent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-10-30 |
| Est. Completion | 2017-05-12 |
| Phase | NA |
Why NCT02431494 stopped before completion
NCT02431494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Blue light phototherapy is the first listed.
NCT02431494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02431494 about?
NCT02431494 is a clinical study titled "Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris". Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations. Although there is consensus that combination therapy is most e...
What is the current status of trial NCT02431494?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-10-30. Estimated completion is 2017-05-12.
What interventions are being tested in trial NCT02431494?
The interventions under investigation include: Blue light phototherapy (DEVICE), Microcurrent therapy (DEVICE), Combination of BLP and Microcurrent (DEVICE).
Who is sponsoring clinical trial NCT02431494?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02431494's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI